Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2021-04-13 Regulatory Filings
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2021-04-13 English
Annual MD&A - English.pdf
Regulatory Filings
2021-04-13 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2021-04-13 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new advisor to the company's board or management team. It contains no financial data, no regulatory form references, no voting results, no financial performance details, and no mention of any report publication. The content focuses on management changes and strategic guidance. Therefore, it fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed information about the appointment, which supports a confident classification.
2021-03-15 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a debt settlement and conversion of debt into shares by PreveCeutical Medical Inc. It details the issuance of shares to creditors as settlement of debt and conversion of a credit facility into shares. The document includes information about the transaction, related party considerations, and regulatory exemptions. It does not contain financial statements, detailed financial analysis, or comprehensive financial results. It is not an earnings release, annual or interim report, or any form of audit or management report. The content is focused on a financing activity involving share issuance to settle debt, which fits the category of Capital/Financing Update. The document length is 8813 characters, which is substantive and not a mere announcement of a report publication. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-03-13 English
News release - English.pdf
Annual Report Classification · 85% confidence The document provides detailed financial ratios related to earnings coverage on subordinated indebtedness, preferred shares, and other equity instruments for the twelve months ended January 31, 2021. It includes specific financial data such as dividend requirements, interest requirements, earnings before interest and taxes, and consolidated ratios of earnings to fixed charges. The content is substantive financial information and analysis for a fiscal year period, indicating it is part of a comprehensive financial report rather than a brief announcement or certification. The document length is 2368 characters, which is relatively short but contains actual financial data and ratios, not just a notice or announcement. Given the detailed financial performance data for a full fiscal year, this aligns best with an Annual Report (10-K) type document, which covers company activity and full financial performance for the year. Therefore, the classification is 10-K with high confidence. FY 2021
2021-02-23 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.